Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |